1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
- The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
- 2006
-
Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies
Karppinen, S. -M. ; Barkardottir, R. B. ; Harbst, Katja LU
; Sydenham, T.
; Syrjakoski, K.
; Schleutker, J.
; Ikonen, T.
; Pylkas, K.
; Rapakko, K.
and Erkko, H.
, et al.
(2006)
In Journal of Medical Genetics
43(11).
p.856-862
Mark
- 2005
-
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
Antoniou, A C ; Pharoah, P D P ; Narod, S ; Risch, H A ; Eyfjord, J E ; Hopper, J L ; Olsson, Håkan LU
; Johannsson, O
; Borg, Åke
LU
and Pasini, B
, et al.
(2005)
In Journal of Medical Genetics
42(7).
p.602-603
Mark
- 2004
- BRCA2 mutations in 154 Finnish male breast cancer patients
- 2003
-
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies
Antoniou, A ; Pharoah, PDP ; Narod, S ; Risch, HA ; Eyfjord, JE ; Hopper, JL ; Loman, Niklas LU ; Olsson, H LU
; Johannsson, O
and Borg, Åke
LU
, et al.
(2003)
In American Journal of Human Genetics
72(5).
p.1117-1130
Mark
- 2002
- A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes
- 2000
- Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus